Edward Chu, M.D., was named deputy director of Yale Cancer Center (YCC), effective January 1. He succeeds José Costa, M.D., who has filled the post for the past 10 years. Costa will remain on the faculty as a professor of pathology and of medicine, vice chair of the Department of Pathology and director of anatomic pathology in the department. Costa will also remain an active member of YCC.
Chu, who is currently professor of medicine and pharmacology and chief of medical oncology, has held positions of increasing responsibility at the center since 1996. In his new role, Chu will continue to lead the Section of Medical Oncology and will also direct the clinical research initiatives for YCC.
Chu is a graduate of Brown University, where he also received his medical degree and completed his residency training. He completed a fellowship in medical oncology at the National Cancer Institute and served as a tenured senior clinical investigator. He came to Yale in 1996 as chief of medical oncology and director of the VA Connecticut Cancer Center at the VA Connecticut Healthcare System in West Haven and as co-director of the Developmental Therapeutics Research Program at YCC.
Chu is the author of Physicians’ Cancer Chemotherapy Drug Manual, a comprehensive review of all major cancer drugs and treatment regimens used in daily clinical practice. The manual, which is now in its seventh edition and is updated annually, is recognized as a leading publication in the field of cancer therapy. Chu is also editor in chief of the journal Clinical Colorectal Cancer and chair of the International Colorectal Congress, an annual meeting that brings together leaders in oncology from the United States, Europe and Asia to present and discuss the latest developments in the management and treatment of colorectal cancer.